ChemicalBook > CAS DataBase List > Osimertinib mesylate

Osimertinib mesylate

Product Name
Osimertinib mesylate
CAS No.
1421373-66-1
Chemical Name
Osimertinib mesylate
Synonyms
Osimertinib;Tagrisso;Osimertinib d6;Mereletinib mesylate;Osimertinib methanesulfonate;Osimertinib (AZD9291) mesylate;N-[2-(2-dimethylaminoethylmethylamino)-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide mesylate salt;N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide methanesulfonate;N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide methanesulfonate (1:1);PB1211
CBNumber
CB82677060
Molecular Formula
C29H37N7O5S
Formula Weight
595.72
MOL File
1421373-66-1.mol
More
Less

Osimertinib mesylate Property

Melting point:
>232°C (dec.)
storage temp. 
-20°C Freezer, Under inert atmosphere
solubility 
DMSO (Slightly), Methanol (Slightly)
form 
Solid
color 
Off-White to Yellow
InChI
InChI=1S/C28H33N7O2.CH4O3S/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24;1-5(2,3)4/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32);1H3,(H,2,3,4)
InChIKey
FUKSNUHSJBTCFJ-UHFFFAOYSA-N
SMILES
S(O)(=O)(=O)C.CN1C2=CC=CC=C2C(C2C=CN=C(NC3C=C(NC(=O)C=C)C(N(C)CCN(C)C)=CC=3OC)N=2)=C1
More
Less

Safety

HS Code 
29339900
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H302Harmful if swallowed

H317May cause an allergic skin reaction

H361Suspected of damaging fertility or the unborn child

H372Causes damage to organs through prolonged or repeated exposure

H400Very toxic to aquatic life

H410Very toxic to aquatic life with long lasting effects

Precautionary statements

P201Obtain special instructions before use.

P202Do not handle until all safety precautions have been read and understood.

P260Do not breathe dust/fume/gas/mist/vapours/spray.

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P272Contaminated work clothing should not be allowed out of the workplace.

P273Avoid release to the environment.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P281Use personal protective equipment as required.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P308+P313IF exposed or concerned: Get medical advice/attention.

P314Get medical advice/attention if you feel unwell.

P321Specific treatment (see … on this label).

P330Rinse mouth.

P333+P313IF SKIN irritation or rash occurs: Get medical advice/attention.

P363Wash contaminated clothing before reuse.

P391Collect spillage. Hazardous to the aquatic environment

P405Store locked up.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

TRC
Product number
A808205
Product name
AZD-9291Mesylate
Packaging
25mg
Price
$45
Updated
2021/12/16
TRC
Product number
A808205
Product name
AZD-9291Mesylate
Packaging
100mg
Price
$60
Updated
2021/12/16
Usbiological
Product number
474070
Product name
AZD 9291 mesylate
Packaging
100mg
Price
$1168
Updated
2021/12/16
ChemScene
Product number
CS-2019
Product name
Osimertinibmesylate
Purity
99.94%
Packaging
1g
Price
$190
Updated
2021/12/16
ChemScene
Product number
CS-0131988
Product name
OsimertinibD6
Purity
99.70%
Packaging
1mg
Price
$420
Updated
2021/12/16
More
Less

Osimertinib mesylate Chemical Properties,Usage,Production

Description

Osimertinib is active against exon 19 deletions, exon 21 mutations, and also the exon 20 T790M mutations. It is preferentially selective for mutated EGFR, and therefore toxicity at therapeutic doses is lower than for first- and second-generation agents. Notably, osimertinib is able to cross the blood-brain barrier, making it active against disease in the CNS.

Uses

Osimertinib mesylate (AZD9291) is the mesylate form of osimertinib, which is an oral, third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) drug.

Application

Osimertinib mesylate is approved to treat: Non-small cell lung cancer that has certain EGFR gene mutations. It is used in adults: As adjuvant therapy after surgery to remove the cancer; As the first therapy for cancer that has spread to other parts of the body, or in patients whose cancer has spread to other parts of the body and got worse during or after treatment with another EGFR tyrosine kinase inhibitor.

Definition

ChEBI: A methanesulfonate (mesylate) salt prepared from equimolar amounts of osimertinib and methanesulfonic acid. Used for treatment of EGFR T790M mutation positive non-small cell lung cancer.

Indications

The collection of ibrutinib (Imbruvica(R), Pharmacyclics Inc.), afatinib, and osimertinib represents the small, yet expanding, group of covalent SMKIs. Ibrutinib is a non-receptor Bruton’s tyrosine kinase inhibitor approved for the treatment of relapsed chronic lymphocytic leukemia. Afatinib, approved for NSCLC in 2013 and squamous NSCLC in 2016, is a second-generation irreversible EGFR inhibitor that targets wild-type EGFR, the mutant T790M EGFR, and HER2. Osimertinib (AZD9291), which was approved by FDA in November 2015, is a third-generation irreversible EGFR inhibitor that selectively targets the mutant T790M EGFR. Rociletinib, which shares a high degree of structural similarity with that of osimertinib, is a promising covalent EGFR inhibitor developed by Clovis Oncology aimed for the treatment of patients with EGFR T790M-mutated NSCLC, until the company terminated its development in May 2016 following a negative vote fromthe FDA’sOncologic Drugs Advisory Committee.

Side effects

Osimertinib toxicity is dose-dependent and is associated with fewer gastrointestinal and dermatologic adverse events than with other approved EGFR TKIs.

Synthesis

Friedel-Crafts arylation of commercial N-methylindole (203) with commercial dichloropyrimidine 202 gave the 3- pyrazinyl indole 204 in good yield. Subsequent SNAr with nitroaniline 205 (available from a one-step nitration from the commercially available des-nitroaniline) provided aminopyrazine 206. Next, SN Ar reaction of 206 with N,N,N??- trimethylated ethylenediamine delivered 207 in near quantitative yield, and this was followed by nitro reduction with iron under acidic conditions to give rise to the triaminated arene 208 in 85% yield. Because acrylates are notoriously difficult to install directly due to their highly reactive nature and propensity to polymerize, a clever two-step acylation/ elimination sequence was employed using 3-chloropropanoyl chloride, and this was immediately followed by mesylate salt formation, which furnished the osimertinib mesylate (XXVI) in excellent yield. This seven-step process which derives from readily available feedstock delivered the final product in nearly 57% overall yield from starting materials 202 and 203.

Osimertinib mesylate Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Osimertinib mesylate Suppliers

Sichuan Welltzpharm Inc.
Tel
028-028-85182370 18183275100
Email
info@welltzpharm.com
Country
China
ProdList
40
Advantage
58
Cangzhou Enke Pharma-tech Co., Ltd.
Tel
0317-5296180 15533709196
Fax
0317-5106596
Email
sale@enkepharma.com
Country
China
ProdList
1648
Advantage
55
Shanghai Mixiu Chemical Co., Ltd.
Tel
18101936766
Fax
021-58583907
Email
eileen@shmychem.com
Country
China
ProdList
351
Advantage
55
Shandong RuiYue Biotechnology Co., Ltd.
Tel
0531-88581623 18805314509
Fax
0531-88581623
Email
1456922171@126.com
Country
China
ProdList
67
Advantage
50
Aktin Chemicals, Inc.
Tel
028-85159085
Email
info@aktinchem.com
Country
China
ProdList
1676
Advantage
58
Hubei Weideli Chemical Reagent Co.,Ltd.
Tel
027-02759222918 13385289472
Email
Z13385289472@163.com
Country
China
ProdList
3354
Advantage
58
Chunchuang (Wuhan) Technology Co., Ltd
Tel
15342225168
Email
yutianchun2007@126.com
Country
China
ProdList
9991
Advantage
58
Guangzhou Reullei Pharmaceutical Technology Co., Ltd,
Tel
18664855715
Email
lx@reullei.com
Country
China
ProdList
299
Advantage
58
TIANJIN PHARMACN MEDICAL TECHNOLOGY CO.,LTD.
Tel
022-60182192,1339732154 18722583064
Fax
86-22-60979672
Email
marketing@pharmacn.com
Country
China
ProdList
112
Advantage
61
Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2923
Advantage
55
More
Less

View Lastest Price from Osimertinib mesylate manufacturers

Shaanxi Haibo Biotechnology Co., Ltd
Product
Osimertinib mesylate 1421373-66-1
Price
US $0.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
2000ton
Release date
2023-09-04
Henan Fengda Chemical Co., Ltd
Product
AZD-9291 Mesylate 1421373-66-1
Price
US $200.00-1.00/KG
Min. Order
1KG
Purity
99%, 99.5% Sublimated
Supply Ability
g-kg-tons, free sample is available
Release date
2024-01-02
Hubei Langyou International Trading Co., Ltd
Product
Osimertinib Mesylate 1421373-66-1
Price
US $1.00/KG
Min. Order
5g
Purity
99%
Supply Ability
1000kgs
Release date
2021-09-01

1421373-66-1, Osimertinib mesylateRelated Search:


  • AZD-9291 (Mesylate)
  • N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide methanesulfonate (1:1)
  • AZD-9291 mesylate N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide methanesulfonate (1:1)
  • Osimertinib
  • N-[2-(2-dimethylaminoethylmethylamino)-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide mesylate salt
  • Osimertinib Mesylate(AZD9291)
  • Osimertinib mesylate
  • Mereletinib mesylate
  • Mereletinib Ms salt
  • AZD9291 Ms salt, Osimertinib Ms salt
  • N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide methanesulfonate
  • Tagrisso
  • N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide methanesulfonate
  • AZD-9291 MESYLATE(OSIMERTINIB)
  • Osimertinib d6
  • N-(2-(N-(2-(dimethylamino)ethyl)-N-methylamino)-4-methoxy-5-((4-(1-methyl-1H-indole-3-yl)pyrimidine-2-yl)amino)phenyl)acrylamide methanesulfonate
  • Osimertinib methanesulfonate
  • Osimertinib (AZD9291) mesylate
  • Mereletinib mesylate, 98%, a potent and selective mutated forms EGFR inhibitor
  • AZD-9291 (MESYLATE);TAGRISSO;OSIMERTINIB MESYLATE
  • AZD-9291 mesylate (Osimertinib mesylate
  • AZD-9291 mesylate (Osimertinib,Mereletinib)
  • MERELETINIB MESYLATE; EGFR INHIBITOR; AZD9291 MESYLATE; AZD 9291 MESYLATE;TAGRISSO
  • Mesylate-AZD9291
  • Osimertinib Mesylate (Tagrisso, Mereletinib, AZD-9291)
  • N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide methanesulfonate(AZD9291 mesylate)
  • Osimertinib Impurity 30
  • Mereletinib mesylateQ: What is Mereletinib mesylate Q: What is the CAS Number of Mereletinib mesylate Q: What is the storage condition of Mereletinib mesylate Q: What are the applications of Mereletinib mesylate
  • Undecanoicacid,15-hydroxy-
  • 2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:1)
  • Osimertinib mesylate (AZD-9291 mesylate)
  • N-2-2-(Dimethylamino)ethylmethylamino-4-methoxy-5-4-(1-methyl-1H-indol-3-yl)-pyrimidin-2-ylaminophenyl-acrylamide methanesulfonate (1:1)
  • Osimertinib Mesylate API
  • Osimeitinib mesylate
  • osimertinib MsOH
  • PB1211
  • 1421373-66-1
  • 421373-66-1
  • C28H33N7O2CH4O3S
  • C29H37N7O5S
  • AZD09
  • API
  • 1421373-66-1